IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression
about
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survivalIMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesisIMP3 signatures of fallopian tube: a risk for pelvic serous cancers.Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.Differential expression of IMP3 between male and female mature teratomas--immunohistochemical evidence of malignant nature.Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodulesExpression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resectionA systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosisPredicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomyp16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.Identification of insulin-like growth factor 2 mRNA-binding protein 3 as a radioresistance factor in squamous esophageal cancer cells.RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.IMP3 and p16 expression in squamous cell carcinoma of the head and neck: A comparative immunohistochemical analysis.Immunohistochemical expression of IMP3 and p53 in inflammatory lesions and neoplastic lesions of the gastric mucosa.IMP3 is upregulated in primary ovarian mucinous carcinoma and promotes tumor progression.Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.Utility of ProExC and IMP3 immunocytochemical staining in atypical glandular cells of undetermined significance in liquid-based cervical cytology.Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings.Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions.Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
P2860
Q33533645-2069C610-300F-485E-B73F-60D6FBACCDC7Q34468574-B74337E2-FD5D-48C7-809A-0B1DED3EC272Q34504360-292186D0-7F04-46DC-9D6D-36C696A91EA0Q35110943-C4893CDC-7CDD-402E-94C7-E5BA5FDE1150Q35113770-2CA7904D-351A-474A-9666-D3F3B1EBF25EQ35125481-FC600C5E-2586-403A-8AAE-E735110E72B9Q35863071-D288FBC5-1BA3-43F5-BD39-9CC7E3844F4BQ35916537-5BCDE9B2-A406-4A16-AEA5-3068B1B75D97Q36087804-D33D3A2F-84D2-4C8B-BC0E-B0AD46AE62F8Q36437698-CF009D6F-7115-48EB-A267-AE32543A800BQ37002361-AE3A8BDA-6B9E-49C3-A959-B8784700A132Q37054556-3A3575A0-2E9B-446B-9470-63384FB943F6Q37181866-0BC35EBE-3C5E-4563-BECC-72827880307EQ37200715-EA697151-58BE-4E70-9F03-1D675571A46BQ37302337-89F41B69-04DC-466D-B151-CF13B01DCFFCQ37406427-21F5D3C5-7B2E-463A-BAFB-724CC6F8878AQ37463112-73581066-6CC5-4586-AA9A-285D91AC009DQ38407148-5E1E9FD7-3B77-4D63-8EF6-AA8F7678B087Q39276310-41E9DBF9-4FCD-4E78-A433-D2B82F03AA4FQ39938111-C2271DAF-3499-47A0-96EB-DA460934B6A8Q40085654-85E605E2-8E7D-46FB-96EB-F35645D8AC52Q40101862-25D8C0A6-E94D-4253-8084-6382BB82A623Q41136544-01CC9D4B-16BA-47FA-961C-4F28A6933BCFQ41364326-6E2BA102-231E-4903-8029-FA300D86F0EEQ42959471-070C9877-495A-4E92-ABBB-4ED5C0C9FB28Q45783352-4897A7AF-B9D4-4DE2-AFA3-E6325EA6356BQ46207048-CD253EEC-87E9-4E7F-93CB-F16F404CCEF3Q47135760-C1D29094-F10A-4D5E-9E6E-EA5E494358DAQ47426765-83A6F541-1525-48B9-A5CB-2585A202A3C1Q47886616-CBEAFF59-F692-4433-9193-DC5938F51ECAQ51812202-6B080F92-5C95-4923-ADD1-E8196D5B830CQ53231589-29398915-6DF9-48B8-978D-1AC8047FDFAEQ53328804-CC438549-972A-4426-82B5-B00EA66C15F1Q53470669-5C665366-2458-4E76-B8A7-EACE1A01E80BQ53876627-8E8604E1-4BFA-4E93-A857-AD52CA903A3F
P2860
IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@ast
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@en
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@nl
type
label
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@ast
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@en
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@nl
prefLabel
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@ast
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@en
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@nl
P2093
P2860
P921
P3181
P1433
P1476
IMP3 is a novel biomarker for ...... son with p16(INK4a) expression
@en
P2093
Armando E Fraire
Bruce A Woda
Cuizhen Li
Karen Dresser
Kenneth L Rock
Zhong Jiang
P2860
P2888
P3181
P356
10.1038/MODPATHOL.3800735
P407
P577
2007-02-01T00:00:00Z
P5875
P6179
1021260206